Skip to main content

Table 1 Characteristics of patients with UC included in the study

From: A diagnostic marker for superficial urothelial bladder carcinoma: lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression

Age at diagnosis, mean (range) 69.6 years (36–93)
Gender, male 94 cases (80.3 %)
pT stage at initial TUR
 pTa 92 cases (78.6 %)
 pT1 15 cases (12.8 %)
 pTis 10 cases (8.6 %)
Cellular grade at initial TUR
 Low 57 cases (48.7 %)
 High 60 cases (51.3 %)
Intravesical BCG therapy 11 cases
Intravesical chemotherapy (epirubicin) 21 cases
Total cystectomy 16 cases
Bladder cancer-specific mortality 6 cases
All-cause mortality 21 cases
  1. BCG, Bacille Calmette–Guérin